This webinar will broadcast at 2:00 PM CDT (Chicago) / 8:00 PM BST (London) / 3:00 AM CST, Sept. 3 (Beijing).
WHAT YOU'LL LEARN:
- Understand the scale of the oral health opportunity in the pet category and where gaps in clinical evidence still exist.
- Explore the clinical science behind BLIS Technologies’ oral microbiome strains, BLIS K12™ and BLIS M18™, as well as Probi’s LP6595 gut health research, and learn how these findings are translating from humans to companion animals.
- Discover how translatable human clinical data is becoming an important trust signal for formulators and brand owners evaluating probiotic ingredients for pet health applications.
- Learn how brands and formulators can translate clinical science into product concepts that meet growing market demand for precise, targeted pet health solutions.
This webinar is sponsored by BLIS Technologies and presented by Petfood Industry.
Speaker Information:
John's career has been driven by a fascination with bacteria — how they cause disease, and how they might also be harnessed to prevent it. This led him to graduate studies at the University of Otago's Department of Microbiology and Immunology, characterizing bacteriocins (antimicrobial molecules produced by bacteria to outcompete rivals). He went on to postdoctoral research with Professor Bob Hancock at the University of British Columbia, studying bacteriocin mode of action, followed by a Research Fellow role at Monash University's School of Pharmacy investigating how pathogens resist them. John joined BLIS Technologies in 2011. As CTO, he leads the Scientific Services Team and oversees R&D, Clinical, Regulatory, and IP, driving the identification, characterization, and development of probiotic bacteria for health benefits. He also holds an adjunct Senior Lecturer position at the University of Otago's Department of Microbiology and Immunology, and serves as a Director on the Boards of the IPA and NZBIOTECH.
Bryan Gray is a B2B marketing leader specializing in commercial strategy and demand generation in the food, nutrition, and dietary supplements industry. As Senior Marketing Manager for Probi's North America commercial team, he leads strategic marketing for Probi's ingredient platforms, spanning sales enablement, customer content, trade show strategy, digital campaigns, and innovation pipeline support. His background spans over a decade at New Hope Network (Informa Markets), serving as Marketing Director, Data & E-commerce, leading brand strategy for titles including Nutrition Business Journal, building a customer data platform, and managing go-to-market strategy across nine B2B products. He began his career in CPG brand management at Ciao Bella Gelato, leading trade marketing strategy. Bryan remains dedicated to translating data and clinical science into commercial growth strategies for better-for-you brands.
Brandy Webb, ND, BSc, is a scientific affairs leader specializing in microbiome research and evidence based product development in the dietary supplements industry. As Scientific Affairs Manager at Probi AB, she translates complex microbiome science into clear, clinically relevant insights that support innovative formulation and practitioner and consumer education. Her background spans nearly two decades across clinical practice, higher education, and industry roles, including serving as Chief Medical Officer and Scientific Advisory Board Chair for a major practitioner brand and Medical Advisor for a pioneering hormone testing laboratory. Dr. Webb previously held fellow, faculty and residency positions at Bastyr University and founded a naturopathic practice where she provided nutritional guidance to support an active, healthy lifespan. She remains dedicated to advancing personalized, preventative healthcare and microbiome-focused innovation through scientific integrity and education.